Table 1.
The characteristics of the patients who underwent lung (lobectomy) or prostate cancer surgery (RARP).
| Control | Ketamine | MD (95% CI) | p value | |
|---|---|---|---|---|
| Age (yrs) | 68.0 ± 7.1 | 67.0 ± 7.9 | 0.9 (−2.0, 3.9) | 0.54 |
| Height (cm) | 163.2 ± 9.3 | 163.1 ± 8.9 | 0.1 (−3.5, 3.7) | 0.96 |
| Weight (kg) | 63.5 ± 11.0 | 65.3 ± 11.5 | −1.8 (−6.3, 2.69 | 0.41 |
| Anesthesia (min) | 249..8 ± 55.5 | 257.0 ± 54.4 | −7.2 (−28.9, 14.4) | 0.51 |
| Surgery (min) | 177.2 ± 50.1 | 183.8 ± 50.7 | −6.6 (−26.5, 13.3) | 0.51 |
| Propofol (mg) | 1231.5 ± 491.2 | 1334.4 ± 446.6 | −103.0 (−288.2, 82.2) | 0.27 |
| Remifentanil (μg) | 2347.2 ± 734.6 | 2635.7 ± 926.4 | −288.6 (−620.3, 43.1) | 0.09 |
| Ketamine (mg) | 0 | 134.0 ± 29.3 | −134.0 (−142.4, −125.6) | <0.001 |
| Fentanyl (μg) | 265 ± 52 | 272 ± 47 | 7 (19, 32) | 0.61 |
| Morphine (mg) | 10 [10, 10] | 10 [10, 10] | NA | 0.76 |
| Aceta (mg) | 819.2 ± 200.4 | 836.5 ± 181.3 | −17.3 (−92.9, 58.1) | 0.65 |
| ΔNLR | 6.0 [2.3, 15.5] | 6.2 [2.6, 14.6] | NA | 0.75 |
| ΔPLR | −6.4 [−15.4, 12.2] | −3.6 [−12.8, 20.6] | NA | 0.27 |
| NRS | 0 [0, 3] | 0 [0, 2.3] | NA | 0.79 |
ΔNLR and ΔPLR = value before-after surgery. Aceta: acetaminophen; MD: mean difference; NA: not analyzed; NLR: neutrophil-lymphocyte ratio; NRS: numerical rating scale; PLR: platelet-lymphocyte ratio; RARP: robot-assisted radical prostatectomy.